Pritikin

Item 7 lays out the entry as remarkably accessible at $5,730-$51,980, covering training, certification, materials, and initial support—no buildout or real estate headaches since it's overlaid on existing facilities. Royalties bite at 16% of hospital outpatient Medicare reimbursements per session or 18.5% for physician offices, plus $50 per patient for educational materials, tying fees directly to billable services. With 145 franchise locations (up from 111 in 2023, a 31% surge) and just 1 corporate unit, the system's health looks solid: only 2 terminations and 2 transfers in the latest FDD year, plus 39 projected new units signaling momentum.

Item 19 disclosures provide the earnings edge, showing franchisees capitalize on per-session reimbursements in a high-demand cardiac space, though actual take-home depends on patient volume and payer mix. This isn't a retail franchise—it's a certification play for established providers, minimizing risk with barriers under $52K while offering scalable revenue from ongoing support. Growth trajectory post-2024 FDD suggests Pritikin ICR could be a stealth gem for cardiology groups eyeing compliant, reimbursable programs amid rising heart disease rates, but volume is king in this reimbursement-driven model.